The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability
Open accessAbstract
IMPORTANCE It is unclear whether differences exist in the magnitude and variability of pro-inflammatory mediators in the different phases of bipolar disorder (BD) and among subjects with BD, as compared to healthy controls. OBJECTIVE To run a comparative meta-analysis of C-Reactive Protein (CRP), IL-1, IL-6, TNF-α in BD vs healthy controls, measuring mean and variability effects on all subjects. Sensitivity analyses include disease activity. DATA SOURCES Systematic review of observational studies in PubMed and PsycInfo up to February 2nd, 2020. STUDY SELECTION Case-control studies reporting inflammatory mediators' levels in BD and controls. DATA EXTRACTION AND SYNTHESIS Summary distribution measures of circulating CRP, IL-1β, IL-6, TNF-α in participants with BD and control groups were extracted. Random-effects multivariate meta-analyses were conducted based on individual study/mediator effect sizes (Hedge's g). Main Outcomes and Measures. Co-primary outcomes were inflammatory mediators' levels (Hedge's g) and variability (coefficient of variance ratio (CVR)) differences between participants with BD across the mood spectrum and controls. RESULTS Out of the initial 729 papers, 72 were assessed and then excluded after full-text review, and ultimately 53 studies were included in the systematic review, while 49 were included in the meta-analysis. The mean age was 36.96 (SD: 9.29) years, and the mean female percentage was 56.31 (SD: 16.61). CRP (g=0.70, 95% CI 0.31-1.09, k=37, BD=2,215 vs HC=3,750), IL-6 (g=0.81, 95% CI 0.46-1.16, k=45, BD=1,956 vs HC=4,106), TNF-α (g=0.49, 95% CI 0.19-0.78, k=49, BD=2,231 vs HC=3,017) were elevated in subjects with BD vs HC, but not IL-1β (g=-0.28, 95% CI -0.68-0.12, k=4, BD=87 vs HC=66). When considering euthymic, depressive, and manic episodes separately, CRP and TNF-α were elevated in both depressive and manic episodes, but not in euthymia, while IL-6 remained elevated regardless of the disease state. No difference in CVR emerged for CRP, IL-1β, and TNF-α, while a lower CVR was observed for IL-6. When considering disease phases, CVR was higher in BD than in HCs for CRP during depressive episodes, lower for IL-6 during euthymia, and higher during manic episodes for CRP, IL-6, and TNF-α. Sensitivity analyses after excluding outliers identified with funnel plot visual inspection, low-quality studies, and considering only studies matched per body mass index confirmed the main results. Meta-regression showed that age (IL-6, TNF-α), gender (CRP), duration of illness (CRP) moderated elevated individual inflammatory levels. Conclusions and Relevance Peripheral pro-inflammatory marker elevations were confirmed in BD. CRP and TNF-α could represent state markers, as they were only elevated during mood episodes, while IL-6 appeared to be a trait marker for BD. Increased variability of specific inflammatory mediators in specific disease active states suggests that a subset of subjects with BD may exhibit elevated inflammation as part of a manic or depressive episode.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627
Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., et al. (2017) · World Psychiatry · doi:10.1002/wps.20420 · Cited by 1,729
Self-citationGoldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Self-citationOsimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937
Self-citationComorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677
Research works printed but not linked: 68
- Aas, 2017, Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses, Brain. Behav. Immun., 65, 342, 10.1016/j.bbi.2017.06.005 · DOI
- Bai, 2015, Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls, Bipolar Disord., 17, 269, 10.1111/bdi.12259 · DOI
- Barbosa, 2013, Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients, J. Psychiatr. Res., 47, 1949, 10.1016/j.jpsychires.2013.08.019 · DOI
- Barbosa, 2012, Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers, J. Affect. Disord., 137, 151, 10.1016/j.jad.2011.12.034 · DOI
- Barbosa, 2012, Increased levels of adipokines in bipolar disorder, J. Psychiatr. Res., 46, 389, 10.1016/j.jpsychires.2011.11.010 · DOI
- Barbosa, 2017, Plasma levels of Tumor Necrosis factor superfamily molecules are increased in bipolar disorder, Clin. Psychopharmacol. Neurosci., 15, 269, 10.9758/cpn.2017.15.3.269 · DOI
- Bender, 2008, Attention should be given to multiplicity issues in systematic reviews, J. Clin. Epidemiol., 61, 857, 10.1016/j.jclinepi.2008.03.004 · DOI
- Berk, 2020, Anti-inflammatory treatment of bipolar depression: promise and disappointment, Lancet Psychiat., 7, 467, 10.1016/S2215-0366(20)30155-3 · DOI
- Brugger, 2017, Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia: a Meta-analysis, JAMA Psychiatry, 74, 1104, 10.1001/jamapsychiatry.2017.2663 · DOI · Paper page
- Chakrabarty, 2019, Inflammatory cytokines and cognitive functioning in early-stage bipolar I disorder, J. Affect. Disord., 245, 679, 10.1016/j.jad.2018.11.018 · DOI
- Civil Arslan, F., Tiryaki, A., Özkorumak Karagüzel, E., Aral, G., Sarıoğlu, O.., İnce, İ., Çankaya, S., Alver, A., n.d. The Relationship of Interleukin-18 and Interleukin-6 Levels with Cognitive Functions in Bipolar Disorder. Turk Psikiyatr. Derg 28(2), 81–88.
- Cunha, 2008, Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder, Eur. Arch. Psychiatry Clin. Neurosci., 258, 300, 10.1007/s00406-007-0797-0 · DOI
- da Silva, 2017, Peripheral insulin-like growth factor 1 in bipolar disorder, Psychiatry Res., 250, 30, 10.1016/j.psychres.2017.01.061 · DOI
- De Berardis, 2008, Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder, Int. J. Immunopathol. Pharmacol., 21, 319, 10.1177/039463200802100208 · DOI
- Dickerson, 2007, Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder, Prog. Neuro-Psychopharmacology Biol. Psychiatry, 31, 952, 10.1016/j.pnpbp.2007.02.018 · DOI
- Doganavsargil-Baysal, 2013, Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder, Hum. Psychopharmacol. Clin. Exp., 28, 160, 10.1002/hup.2301 · DOI
- Fernandes, 2020, Editorial: back to the future: on the road towards precision Psychiatry, Front. Psychiatry, 11, 112, 10.3389/fpsyt.2020.00112 · DOI
- Fernandes, 2017, The new field of ‘precision psychiatry’, BMC Med., 15, 80, 10.1186/s12916-017-0849-x · DOI · Paper page
- Firth, 2019, The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness, The Lancet Psychiatry, 6, 675, 10.1016/S2215-0366(19)30132-4 · DOI · Paper page
- Fonseka, 2015, Novel investigational drugs targeting IL-6 signaling for the treatment of depression, Expert Opin. Investig. Drugs, 10.1517/13543784.2014.998334 · DOI
- Fusar-Poli, 2018, Semistructured Interview for Bipolar At Risk States (SIBARS), Psychiatry Res., 264, 302, 10.1016/j.psychres.2018.03.074 · DOI
- Glaus, 2018, Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study, Psychol. Med., 48, 961, 10.1017/S0033291717002744 · DOI
- He, 2020, Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of Disease Study 2017, J. Psychiatr. Res., 125, 96, 10.1016/j.jpsychires.2020.03.015 · DOI
- Higgins, 2008, Meta-analysis of skewed data: combining results reported on log-transformed or raw scales, Stat. Med., 27, 6072, 10.1002/sim.3427 · DOI · Paper page
- Hope, 2015, Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls, Schizophr. Res., 165, 188, 10.1016/j.schres.2015.04.004 · DOI
- Hope, 2009, Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor, Bipolar Disord., 11, 726, 10.1111/j.1399-5618.2009.00757.x · DOI
- Hornig, 1998, Positive and negative acute phase proteins in affective subtypes, J. Affect. Disord., 49, 9, 10.1016/S0165-0327(97)00180-8 · DOI
- Hung, 2007, Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder, Clin. Endocrinol. (Oxf), 67, 784, 10.1111/j.1365-2265.2007.02963.x · DOI
- Jacoby, 2016, Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar i disorder - results from a prospective study, J. Affect. Disord., 197, 167, 10.1016/j.jad.2016.03.040 · DOI
- Kapczinski, 2011, Peripheral biomarkers and illness activity in bipolar disorder, J. Psychiatr. Res., 45, 156, 10.1016/j.jpsychires.2010.05.015 · DOI · Paper page
- Karabulut, 2019, Inflammation and neurodegeneration in patients with early-stage and chronic bipolar disorder, Turkish J. Psychiatry, 30
- Kauer-Sant'Anna, 2009, Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder, Int. J. Neuropsychopharmacol., 12, 447, 10.1017/S1461145708009310 · DOI · Paper page
- Kessing, 2015, Causes of decreased life expectancy over the life span in bipolar disorder, J. Affect. Disord., 180, 142, 10.1016/j.jad.2015.03.027 · DOI · Paper page
- King, 2019, Inflammation, glutamate, and cognition in bipolar disorder type II: a proof of concept study, Front. Psychiatry, 10, 10.3389/fpsyt.2019.00066 · DOI
- Koga, 2019, Altered polyunsaturated fatty acid levels in relation to proinflammatory cytokines, fatty acid desaturase genotype, and diet in bipolar disorder, Transl. Psychiatry, 9, 208, 10.1038/s41398-019-0536-0 · DOI
- Lesh, 2018, Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms, J. Neuroinflammation, 15, 10.1186/s12974-018-1197-2 · DOI
- Maes, 2014, Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?, Expert Opin. Ther. Targets, 18, 495, 10.1517/14728222.2014.888417 · DOI · Paper page
- Manchia, 2020, Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action, Eur. Neuropsychopharmacol., 36, 121, 10.1016/j.euroneuro.2020.05.006 · DOI
- Mao, 2018, Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression, J. Affect. Disord., 237, 65, 10.1016/j.jad.2018.04.115 · DOI · Paper page
- McIntyre, 2019, Efficacy of Adjunctive Infliximab vs Placebo in the treatment of adults with Bipolar I/II depression: a randomized clinical trial, JAMA psychiatry, 76, 783, 10.1001/jamapsychiatry.2019.0779 · DOI · Paper page
- Milaneschi, 2020, Depression heterogeneity and its biological underpinnings: toward immunometabolic depression, Biol. Psychiatry, 88, 369, 10.1016/j.biopsych.2020.01.014 · DOI · Paper page
- Mizuno, 2016, Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: a cross-sectional study, Schizophr. Res., 175, 148, 10.1016/j.schres.2016.04.047 · DOI
- Modabbernia, 2013, Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies, Biol. Psychiatry, 74, 15, 10.1016/j.biopsych.2013.01.007 · DOI · Paper page
- Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, J. Clin. Epidemiol., 62, 1006, 10.1016/j.jclinepi.2009.06.005 · DOI · Paper page
- Mondin, 2016, Circadian preferences, oxidative stress and inflammatory cytokines in bipolar disorder: a community study, J. Neuroimmunol., 301, 23, 10.1016/j.jneuroim.2016.10.012 · DOI
- Mora, 2019, High BDNF serum levels are associated to good cognitive functioning in bipolar disorder, Eur. Psychiatry, 60, 97, 10.1016/j.eurpsy.2019.02.006 · DOI
- Morris, 2019, Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders, Neurosci. Biobehav. Rev., 107, 862, 10.1016/j.neubiorev.2019.09.025 · DOI
- Munkholm, 2015, Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients, Brain. Behav. Immun., 43, 205, 10.1016/j.bbi.2014.09.021 · DOI
- Ortiz-Domínguez, 2007, Immune variations in bipolar disorder: phasic differences, Bipolar Disord., 9, 596, 10.1111/j.1399-5618.2007.00493.x · DOI · Paper page
- Pan, 2020, Excess mortality and shortened life expectancy in people with major mental illnesses in Taiwan, Epidemiol. Psychiatr. Sci., 29, 10.1017/S2045796020000694 · DOI
- Pandey, 2015, Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder, Bipolar Disord., 17, 636, 10.1111/bdi.12320 · DOI
- Pantović-Stefanović, 2018, sVCAM-1, sICAM-1, TNF-α and IL-6 levels in bipolar disorder type I: acute, longitudinal and therapeutic implications, World J. Biol. Psychiatry, 19, S41, 10.1080/15622975.2016.1259498 · DOI
- Quidé, 2019, Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder, Psychol. Med., 49, 2736, 10.1017/S0033291718003690 · DOI
- Remlinger-Molenda, 2012, Activity of selected cytokines in bipolar patients during manic and depressive episodes, Psychiatr. Pol., 46, 599
- Sanjay, 2017, Plasma interleukin-6 in remitted early bipolar I disorder and subjects at high-risk for bipolar disorder, Asian J. Psychiatr., 10.1016/j.ajp.2017.03.014 · DOI
- Sayana, 2017, A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients, J. Psychiatr. Res., 92, 160, 10.1016/j.jpsychires.2017.03.018 · DOI · Paper page
- Scola, 2016, Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder, J. Affect. Disord., 192, 176, 10.1016/j.jad.2015.12.020 · DOI
- Stroup, 2000, MOOSE guidelines for meta-analyses and systematic reviews of observational studies, JAMA
- Tsai, 2012, Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder, J. Affect. Disord., 136, 110, 10.1016/j.jad.2011.08.022 · DOI
- Tunç, 2019, Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study, Psychiatry Clin. Psychopharmacol., 29, 307, 10.1080/24750573.2019.1584489 · DOI
- van den Ameele, 2018, Markers of inflammation and monoamine metabolism indicate accelerated aging in bipolar disorder, Front. Psychiatry, 9, 10.3389/fpsyt.2018.00250 · DOI
- Vasconcelos-Moreno, 2017, Telomere length, oxidative stress, inflammation and BDNF levels in siblings of patients with bipolar disorder: implications for accelerated cellular aging, Int. J. Neuropsychopharmacol., 20, 445, 10.1093/ijnp/pyx001 · DOI
- Vieta, 2015, Personalized medicine applied to mental health: precision psychiatry, Rev. Psiquiatr. y Salud Ment. (English Ed.), 8, 117
- Wadee, 2002, Serological observations in patients suffering from acute manic episodes, Hum. Psychopharmacol., 17, 175, 10.1002/hup.390 · DOI
- Wang, 2016, The differential levels of inflammatory cytokines and bdnf among bipolar spectrum disorders, Int. J. Neuropsychopharmacol., 19, 1, 10.1093/ijnp/pyw012 · DOI
- Wieck, 2014, Pro-inflammatory cytokines and soluble receptors in response to acute psychosocial stress: differential reactivity in bipolar disorder, Neurosci. Lett., 10.1016/j.neulet.2014.07.040 · DOI
- Wiener, 2017, Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder, J. Neuroimmunol., 307, 33, 10.1016/j.jneuroim.2017.03.003 · DOI
- Wu, 2017, Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: A preliminary study, Sci. Rep., 7
Cited by
The role of adipokines in health and disease
Clemente-Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., Martínez-Guardado, I., Navarro-Jiménez, E., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2023) · Biomedicines · doi:10.3390/biomedicines11051290 · Cited by 463
Vasupanrajit, A., Jirakran, K., Tunvirachaisakul, C., Solmi, M., & Maes, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01407-4 · Cited by 109
Self-citationAlmulla, A. F., Thipakorn, Y., Vasupanrajit, A., Tunvirachaisakul, C., Oxenkrug, G., Al-Hakeim, H. K., & Maes, M. (2022) · Cells · doi:10.3390/cells11193112 · Cited by 31
Korkmaz, Ş. A., Kızgın, S., Oğuz, E. F., Neşelioğlu, S., & Erel, Ö. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.07.079 · Cited by 24
Cavaleri, D., Cucchi, G., Citton, M., Monti, M., Crocamo, C., Bartoli, F., & Carrà, G. (2026) · European Psychiatry · doi:10.1192/j.eurpsy.2026.10174 · Cited by 7
Metadata
- Authors
- Solmi, M., Suresh Sharma, M., Osimo, E. F., Fornaro, M., Bortolato, B., Croatto, G., Miola, A., Vieta, E., Pariante, C. M., Smith, L., Fusar-Poli, P., Shin, J. I., Berk, M., & Carvalho, A. F.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 97
- Pages
- 193-203
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W3186181241
- Cited by
- 196
- References
- 30
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- National Health and Medical Research Council (1156072)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability. https://app.cochat.ai/papers/10.1016/j.bbi.2021.07.014
- The paper
- Solmi, M., Suresh Sharma, M., Osimo, E. F., Fornaro, M., Bortolato, B., Croatto, G., Miola, A., Vieta, E., Pariante, C. M., Smith, L., Fusar-Poli, P., Shin, J. I., Berk, M., & Carvalho, A. F. (2021). Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2021.07.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.